Journals / KONURALP TIP DERGİSİ / 2022 / Cilt: 14 - Sayı: 2

Clinicopathological features of Gastrointestinal Stromal Tumors and review of the literature

Gastrointestinal Stromal Tümörlerin Klinikopatolojik Özellikleri ve Literatürün Gözden Geçirilmesi: Tek Merkez Deneyimi

Pages
373–379
Publication Date
2022-06-29
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Further studies with larger series of GISTs consisting of different types of biopsy materials may help define criteria to predict prognosis precisely.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal neoplasias of the gastrointestinal system (GIS).
📊
Key Findings & Data:Method: A total of 28 GIST cases were included in the study.
💡
Conclusion & Impact:Further studies with larger series of GISTs consisting of different types of biopsy materials may help define criteria to predict prognosis precisely.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Gastrointestinal Stromal Tümör · CD17 · DOG-1

Abstract

Objective: Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal neoplasias of the gastrointestinal system (GIS). The malignancy potential of GISTs may vary ranging from indolent tumors to progressive malignant tumors. This study aims to define clinicopathological and immunohistochemical features of GISTs diagnosed in our institute with a review of the literature. Method: A total of 28 GIST cases were included in the study. The Hematoxylin&Eosin stained slides of surgical resection materials and cell blocks and immunohistochemistry performed slides were reviewed by a pathologist. The immunohistochemical expression with CD117, DOG-1, CD34, SMA, and S100 was scored between 0 and 3 points according to staining intensity. Descriptive statistics were used in the study. The demographic data, prognostic histopathological, and immunohistochemical findings are evaluated with the literature indications. Result: Eleven of the cases were male and seventeen were female. The age range was 18-88. The most common site of GISTs was the stomach, followed by the small intestine, colorectal region, and, esophagus. Twenty of the tumors were resected surgically, four were endoscopic biopsy material and four were fine-needle aspiration biopsies. The tumor size in measurable materials ranged from 0,2 to 22 cm. The mitotic count in 50 HPF ranges from 0 to 10. Seven of the GISTs were high grade and the remaining 21 were low grade. The majority of the cases were composed of spindle cells, 3 were epithelioid and 3 were the mixed type with spindle and epitheloid cells. Conclusion: A variety of criteria has been proposed to estimate the malignancy potential of GISTs and predict prognosis but definite prognostic criteria remain uncertain. Further studies with larger series of GISTs consisting of different types of biopsy materials may help define criteria to predict prognosis precisely.

Özet

Amaç: Gastrointestinal stromal tümörler (GİST) gastrointestinal sistemin en sık görülen mezenşimal neoplazileridir. GİST’lerin malignite potansiyeli indolen tümörlerden progresif malign tümörlere kadar değişken olabilir. Bu çalışmada merkezimizde tanı almış GİST’lerin klinikopatolojik ve immünohistokimyasal özelliklerini literatür eşliğinde gözden geçirmek amaçlanmıştır. Gereç ve Yöntem: Toplam 28 GİST olgusu çalışmaya dahil edilmiştir. Cerrahi rezeksiyon materyalleri ile hücre bloklarından hazırlanan Hematoksilen&Eozin boyalı preparatlar ile immünohistokimya uygulanmış preparatlar patoloji uzmanı tarafından değerlendirilmiştir. CD117, DOG-1, CD34, SMA ve S100 immünohistokimyasal ekspresyonları boyanma yoğunluğuna göre 0-3 puan arasında skorlanmıştır. Çalışmada deskriptif istatistikler kullanılmıştır. Demografik bulgular, prognostik histopatolojik ve immünohistokimyasal sonuçlar literatür eşliğinde değerlendirilmiştir. Bulgular: Olguların 11’i erkek, 7’si kadındı. Yaş aralığı 18-88 arasındaydı. GİST’ler için en sık görülen lokasyon mide olup bunu ince barsak, kolorektal bölge ve özofagus takip etmekteydi. Tümörlerin 20’si cerrahi olarak çıkarılmış olup, 4’ü endoskopik biyopsi, kalan 4’ü ince iğne aspirasyon biyopsi materyaliydi. Tümör çapı ölçülebilen materyallerde tümör çapı 0,2 ile 22 cm arasındaydı. 50 büyük büyütme alanında mitoz sayısı 0 ile 10 arasındaydı. GİST’lerin 7’si yüksek dereceli, 21’i düşük dereceliydi. Olguların çoğunluğu iğsi hücrelerden oluşmakta olup, 3’ü epiteloid, 3’ü mikst tipteydi. Sonuç: GİST’lerin malignite potansiyelini tahmin etmek için çeşitli kriterler öne sürülmüş olsa da kesin prognostik kriterler belirlenmemiştir. Çeşitli biyopsi materyallerinden oluşan daha büyük vaka serilerinde yapılacak çalışmalar prognozu daha kesin öngörebilecek kriterlerin belirlenmesine yardımcı olacaktır.

🔖

Cite This Article

COŞKUN, S. K. (2022). Clinicopathological features of Gastrointestinal Stromal Tumors and review of the literature. KONURALP TIP DERGİSİ, Cilt: 14 - Sayı: 2, 373–379. https://ajindex.com/articles/686637

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Wang MX, Devine C, Segaran N, Ganeshan D. Current update on molecular cytogenetics, diagnosis and management of gastrointestinal stromal tumors. World J Gastroenterol. 2021; 27(41): 7125-7133
  2. Lokuhetty D, White VA, Watanabe R, Cree IA. WHO Classification of Digestive System Tumors. IARC: Lyon,2019
  3. Chantharasamee J, Adashek JJ, Wong K, Eckardt MA, Chmielowski B, Dry S et al. Translating Knowledge About the Immune Microenvironment of Gastrointestinal Stromal Tumors into Effective Clinical Strategies. Curr Treat Options Oncol. 2021;22(1):9
  4. Mantese G. Gastrointestinal stromal tumor: epidemiology, diagnosis, and treatment. Curr Opin Gastroenterol. 2019;35(6):555-559
  5. Ogun GO, Adegoke OO, Rahman A, Egbo OH. Gastrointestinal Stromal Tumours (GIST): A Review of Cases from Nigeria. J Gastrointest Cancer. 2020;51(3):729-737
  6. Landi B, Blay JY, Bonvalot S, Brasseur M, Coindre JM, Emile JF et al. Gastrointestinal stromal tumours (GISTs): French Intergroup Clinical Practice Guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO). Dig Liver Dis. 2019;51(9):1223-1231
  7. Huss s, Pasternack H, Ihle MA, Merkelbach-Bruse S, Heitkötter B, Hartmann W et al. Clinicopathological and molecular features of a large cohort of gastrointestinal stromal tumors (GISTs) and review of the literature: BRAF mutations in KIT/PDGFRA wild-type GISTs are rare events. Hum Pathol. 2017;62:206-214
  8. Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998;279:577-580
  9. Minhas S, Bhalla S, Jauhri M, Ganvir M, Aggarwal S. Clinico-Pathological Characteristics and Mutational Analysis of Gastrointestinal Stromal Tumors from India: A Single Institution Experience. Asian Pac J Cancer Prev. 2019;20(10):3051-3055
  10. Mehren M, Joensuu H. Gastrointestinal Stromal Tumors. J Clin Oncol. 2018;36(2):136-143
  11. Hwang DG, Qian X, Hornick JL. DOG1 antibody is a highly sensitive and specific marker for gastrointestinal stromal tumors in cytology cell blocks. Am J Clin Pathol. 2011;135(3):448-53
  12. Jansen K, Farahi N, Büscheck F, Lennartz M, Luebke AM, Burandt E et al. DOG1 expression is common in human tumors: A tissue microarray study on more than 15,000 tissue samples. Pathol Res Pract. 2021;228:153663
  13. Hirota S, Isozaki K. Pathology of gastrointestinal stromal tumors. Pathol Int. 2006;56(1):1-9
  14. Miettinen M, Lasota J. Gas